CORRECTION
Friday, 10 September, 2004
An article published on September 8, headlined 'Nucleonics challenges Benitec-CSIRO RNAI patent' contained errors relating to the timing of the filing of key patents.
It should have stated that a patent application by The Carnegie Institution of Washington and The University of Massachusetts (the Fire-Mello invention) was first filed in the US in December 1997. The Fire-Mello invention has an earlier priority date than the Benitec and CSIRO applications, which were first filed in Australia.
A patent application by Syngenta, directed to a vector for enhancing the inhibition of a selected target gene, was also filed before the Benitec and CSIRO applications.
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
Breast augmentation procedure uses 3D-printed scaffolds
3D-printed scaffold technology from medtech company BellaSeno has been used in a primary breast...
